We are happy to announce the addition of a new postdoc to our group. Please welcome Dr. Pier Giorgio Amendola.
Pier is an Italian postdoctoral scientist with a solid background in molecular and cellular biology. Pier earned his Msc in Molecular Biology at the Weizmann Institute of Science in Israel, studying the role of the tumor suppressor p53 in cellular differentiation and cancer. During his PhD at BRIC, University of Copenhagen, Pier discovered a novel function for a histone modifier in DNA Damage Response, a pathway which is frequently compromised in several tumors. In the Erler lab, Pier is focusing his efforts on the development of new effective anti-metastatic therapies with the aim of improving current treatments, including the survival and well-being of human patients. We are very excited to have Pier in the lab and we look forward to follow the project progress.